Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 30, 2006American Journal of Respiratory and Critical Care MedicineOpen Access

Potent Twice-Weekly Rifapentine-containing Regimens in Murine Tuberculosis

View Full Paper
Ask AI
Bookmark
Share

Authors

IRIan M. RosenthalJohns Hopkins UniversityKWKathy N. WilliamsMedical University of South CarolinaSTSandeep TyagiJohns Hopkins University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Rosenthal et al. (2006) studied this question.

synapsesocial.com/papers/6a73e99c6acfb9d2a78ded54https://doi.org/10.1164/rccm.200602-280oc
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1U.S. Public Health Service Cooperative trial of three rifampin-isoniazid regimens in treatment of pulmonary tuberculosis.1979 · 103 citations
  2. 2Low Isoniazid Concentrations and Outcome of Tuberculosis Treatment with Once-Weekly Isoniazid and Rifapentine2003 · 194 citations
  3. 3Acquired Rifamycin Resistance with Twice-Weekly Treatment of HIV-related Tuberculosis2005 · 155 citations
  4. 4Powerful bactericidal activity of sparfloxacin (AT-4140) against Mycobacterium tuberculosis in mice1993 · 90 citations
  5. 5Antituberculosis Activity of Once-weekly Rifapentine-containing Regimens in Mice: Long-term Effectiveness with 6- and 8-Month Treatment Regimens2000 · 31 citations